Braveheart Bio, Inc. Common Stock Financial Flexibility Index
Braveheart Bio, Inc. Common Stock financial flexibility index. Braveheart Bio, Inc. Common Stock (BRVE) has a Financial Flexibility Index of -0.08x as of June 2026. Free cash flow of $-16.95 Million (operating CF $-16.95 Million minus capex $0.00) represents 0% of total liabilities ($222.86 Million). Read Braveheart Bio, Inc. Common Stock debt and liabilities for a breakdown of total debt and financial obligations.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Braveheart Bio, Inc. Common Stock (2025–2025)
Financial flexibility index of Braveheart Bio, Inc. Common Stock from 2025 to 2025. Historical Financial Flexibility Index trend for Braveheart Bio, Inc. Common Stock across 1 annual periods. Explore Braveheart Bio, Inc. Common Stock (BRVE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Braveheart Bio, Inc. Common Stock Financial Flexibility Index by Year (2025–2025)
Braveheart Bio, Inc. Common Stock financial flexibility index by year from 2025 to 2025. Year-by-year free cash flow to debt coverage for Braveheart Bio, Inc. Common Stock. For the full cash flow conversion analysis, see Braveheart Bio, Inc. Common Stock (BRVE) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | $31.55 Million | $-2.01 Million | $155.22 Million | — |